Patients with choledocholithiasis have been shown to have a high incidence of acute cholecystitis after endoscopic treatment of bile duct stones. This study assessed the necessity of cholecystectomy for gallstones after treatment of choledocholithiasis in elderly patients aged ≥80 years. The rate of biliary troubles and mortality according to the presence or absence of cholecystectomy were studied as well.
Of the 314 patients who underwent endoscopic retrograde cholangiopancreatography for common bile duct stones in a Japanese hospital over 5 years (2011-2016), 197 patients had gallstones. The current retrospective analysis compared 106 cases aged ≤79 years (young group) with 91 cases aged ≥80 years (elderly group). The patient background differed between both groups regarding sex ratio and mean common bile duct diameter. The mean observation period was not different in both groups.
Cholecystectomy was performed in 51% of the young group and 9% of the elderly group. The rate of surgery was significantly lower in the elderly group. Postoperative biliary troubles occurred in 18% of the young group and 30% of the elderly group. Cholecystectomy significantly reduced the risk of biliary problems in the young group, but there was no significant difference in mortality. There were no significant differences in biliary trouble and death in the elderly group.
This study showed that the presence or absence of cholecystectomy does not affect biliary tract problems or death in elderly people ≥80 years old. Follow-up may be appropriate without surgery. Further studies with larger sample sizes are needed.
- Kodama R. Study of the necessity of cholecystectomy after treatment of choledocholithiasis for elderly patients. UEG Week Virtual Symposium 2020, abstract OP187.
Posted on
Previous Article
« No improvements of remission with etrolizumab in ulcerative colitis Next Article
Probiotic provides a potential adjuvant treatment to gluten-free diet »
« No improvements of remission with etrolizumab in ulcerative colitis Next Article
Probiotic provides a potential adjuvant treatment to gluten-free diet »
Table of Contents: UEGW 2020
Featured articles
Risk factors for severe COVID-19 among IBD patients
UEGW Round-Up Articles
Sustained efficacy of mirikizumab in moderate-to-severe Crohn’s disease
Low-FODMAPs diet does not improve PPI-refractory GERD
Probiotic provides a potential adjuvant treatment to gluten-free diet
Cholecystectomy does not affect mortality in elderly patients
No improvements of remission with etrolizumab in ulcerative colitis
Filgotinib effective as maintenance treatment for ulcerative colitis
Possible causal link between eosinophilic inflammation and anxiety
Dupilumab improves in diverse aspects of eosinophilic oesophagitis
Plecanatide effective for IBS with constipation
Sustained response to faecal microbiota transplantation
Endoscopy can be delivered safely during the COVID-19 pandemic
Adenoma detection rate improves over time
Post-colonoscopy colorectal cancers in IBD patients
Risk factors for severe COVID-19 among IBD patients
First randomised T2T trial using endoscopy to guide dose escalation
Related Articles
September 28, 2021
Could steroid treatment speed recovery from infliximab-induced liver injury?
March 23, 2022
Pfizer’s bowel disease drug succeeds in late-stage study
April 12, 2022
VEDOKIDS: Vedolizumab seems effective in paediatric IBD
© 2024 Medicom Medical Publishers. All rights reserved. Terms and Conditions | Privacy Policy
HEAD OFFICE
Laarderhoogtweg 25
1101 EB Amsterdam
The Netherlands
T: +31 85 4012 560
E: publishers@medicom-publishers.com